| All Races | Asian/Other | Black | Hispanic | White | ||||||||
| Histology (ICD-O) (1) | Cases | % | Cases | % | Cases | % | Cases | % | Cases | % | ||
| TOTAL | 11,436 | 100.00 | 582 | 100.0 | 533 | 100.0 | 866 | 100.0 | 9,271 | 100.0 | ||
| Epidermoid carcinoma (8051-8130) | 3 | 0.00 | 1 | 0.0 | 1 | 0.2 | 0 | 0.0 | 1 | 0.0 | ||
| Adenocarcinoma | 11,192 | 97.90 | 561 | 96.4 | 522 | 97.9 | 846 | 97.7 | 9,080 | 97.9 | ||
| Non-infiltrating intraductal carcinoma, NOS (8500) | 6,307 | 55.20 | 319 | 54.8 | 315 | 59.1 | 470 | 54.3 | 5,113 | 55.2 | ||
| Non-infiltrating comedocarcinoma (8501) | 2,051 | 17.90 | 118 | 20.3 | 70 | 13.1 | 144 | 16.6 | 1,699 | 18.3 | ||
| Lobular carcinoma in situ (8520,8521) | 1,580 | 13.80 | 40 | 6.9 | 59 | 11.1 | 123 | 14.2 | 1,309 | 14.1 | ||
| Intraductal and lobular carcinoma in situ (8522) | 432 | 3.80 | 14 | 2.4 | 17 | 3.2 | 42 | 4.9 | 346 | 3.7 | ||
| Papillary adenocarcinoma in situ (8050,8260,8503) | 619 | 5.40 | 54 | 9.3 | 44 | 8.3 | 56 | 6.5 | 457 | 4.9 | ||
| Other adenocarcinoma in situ | 203 | 1.80 | 16 | 2.8 | 17 | 3.2 | 11 | 1.3 | 156 | 1.7 | ||
| All other carcinoma in situ | 241 | 2.10 | 20 | 3.4 | 10 | 1.9 | 20 | 2.3 | 190 | 2.0 | ||
Source: California Cancer Registry, November 1994. Excludes lymphohematopoietic neoplasms of the breast (ICD-O, Field Trial edition, histology codes 9590-9970) (2).
1 Numbers in parentheses are ICD-O, Field Trial edition, histology codes (2). Where not specified, groups are as defined by Berg (10). NOS=not otherwise specified.
2 Race/ethnicity categories are mutually exclusive. Persons of Hispanic ethnicity are identified by medical record and/or surname, and may be of any race. Persons of unknown race/ethnicity are excluded from race-specific data.
Return to Table of Contents
Return to Chapter 5
Return to Table 5.14